Abstract: A discharging control method and a charging control method for a rechargeable battery, and the rechargeable battery. An electric system of the rechargeable battery comprises a lithium ion cell and a discharging control circuit, and a charging control circuit. A positive electrode of the lithium ion cell is electrically connected to a common ground end (GND) of the charging and/or discharging control circuit, so that the common ground end (GND) serves as a positive electrode (P) of the charging input and/or discharging output of the rechargeable battery; a negative electrode of the lithium ion cell is electrically connected to an output end of the charging control circuit and an input end of the discharging control circuit; and the input end of the charging control circuit and the output end of the discharging control circuit are electrically connected to a negative electrode (N) of the rechargeable battery.

Abstract: A discharging control method and a charging control method for a rechargeable battery, and the rechargeable battery. An electric system of the rechargeable battery comprises a lithium ion cell and a discharging control circuit, and a charging control circuit. A positive electrode of the lithium ion cell is electrically connected to a common ground end (GND) of the charging and/or discharging control circuit, so that the common ground end (GND) serves as a positive electrode (P) of the charging input and/or discharging output of the rechargeable battery; a negative electrode of the lithium ion cell is electrically connected to an output end of the charging control circuit and an input end of the discharging control circuit; and the input end of the charging control circuit and the output end of the discharging control circuit are electrically connected to a negative electrode (N) of the rechargeable battery.

Abstract: The present invention relates to a recombinant microorganism expressing avermectin or analogs thereof and construction method thereof, and also relates to a method of producing avermectin or analogs thereof using the recombinant microorganism, and avermectin or analogs thereof obtained using the method. In addition, the present invention further relates to uses of the avermectin or analogs thereof as insecticides. Using the recombinant microorganism of the present invention to produce avermectin or analogs thereof has numerous advantages, for example comprising at least one of the following: good stability, high yield, simple process, environmentally friendly, and greatly saving of production costs.

Abstract: Disclosed herein are compounds tenvermectin A and B and mixtures of compounds tenvermectin A and B for preventing and treating human or animal parasitic infection. Tenvermectin A and B are macrolide compounds and are produced by genetically engineered bacteria. Tenvermectin A and B are structurally similar to avermectin, ivermectin, milbemycin and emamectin benzoate. The toxicities of tenvermectin A and B are significantly lower than avermectin, ivermectin, milbemycin and emamectin benzoate. The disclosed compounds and mixture of compounds belong to a class of compounds that are useful for killing and eliminating parasites, such as nematodes or arthropods.

Abstract: The present invention relates to a recombinant microorganism expressing avermectin or analogues thereof and construction method thereof, and also relates to a method of producing avermectin or analogues thereof using the recombinant microorganism, and avermectin or analogues thereof obtained using the method. In addition, the present invention further relates to uses of the avermectin or analogues thereof as insecticides. Using the recombinant microorganism of the present invention to produce avermectin or analogues thereof has numerous advantages, for example comprising at least one of the following: good stability, high yield, simple process, environmentally friendly, and greatly saving of production costs.